124 related articles for article (PubMed ID: 34763625)
1. Association Between ACOX1 and NRF1 Gene Expression and Hepatitis B and C Virus Infections and Hepatocellular Carcinoma in Liver Transplant Patients (Shiraz, Iran).
Abdolyousefi EN; Motalleb G; Yaghobi R
Exp Clin Transplant; 2022 Jan; 20(1):52-58. PubMed ID: 34763625
[TBL] [Abstract][Full Text] [Related]
2. Association of the Interleukin-27 Gene Expression and Hepatitis B Virus Infection in Liver Transplanted Patients.
Zare A; Karimi MH; Rashki A; Geramizadeh B; Afshari A; Miri HR; Yaghobi R
Exp Clin Transplant; 2017 Oct; 15(5):554-560. PubMed ID: 26925776
[TBL] [Abstract][Full Text] [Related]
3. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
5. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
[TBL] [Abstract][Full Text] [Related]
6. Expression Profile of Interferon Regulatory Factor 1 in Chronic Hepatitis B Virus-Infected Liver Transplant Patients.
Janfeshan S; Yaghobi R; Eidi A; Karimi MH; Geramizadeh B; Malekhosseini SA; Kafilzadeh F
Exp Clin Transplant; 2017 Dec; 15(6):669-675. PubMed ID: 27310137
[TBL] [Abstract][Full Text] [Related]
7. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
8. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma.
Tanase AM; Dumitrascu T; Dima S; Grigorie R; Marchio A; Pineau P; Popescu I
Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):162-72. PubMed ID: 24686543
[TBL] [Abstract][Full Text] [Related]
9. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
[TBL] [Abstract][Full Text] [Related]
10. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
[TBL] [Abstract][Full Text] [Related]
12. Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.
Zhou J; Huang Z; Chen Z; Xu F; Tong R; Zheng S
BMC Gastroenterol; 2021 Apr; 21(1):195. PubMed ID: 33931011
[TBL] [Abstract][Full Text] [Related]
13. Morphologic and Immunologic Characteristics of Hepatocellular Carcinoma for Prognosis of Surgical Intervention.
Ismailova G; Yenin E; Kaniev S; Bayguisova D; Tajibaev T
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):140-144. PubMed ID: 29528012
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
15. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation.
Lu D; Zhuo J; Yang M; Wang C; Pan L; Xie H; Xu X; Zheng S
Gene; 2018 Jul; 663():121-125. PubMed ID: 29627528
[TBL] [Abstract][Full Text] [Related]
16. Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma.
Zhu JQ; Ye XY; Yang SW; Liu JZ; Ren ZY; Jia YN; Liu Z; Ding C; Kou JT; Li XL; Han DD; He Q
Eur J Clin Nutr; 2024 Feb; 78(2):107-113. PubMed ID: 37935889
[TBL] [Abstract][Full Text] [Related]
17. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil.
Branco F; Mattos AA; Coral GP; Vanderborght B; Santos DE; França P; Alexandre C
Arq Gastroenterol; 2007; 44(1):58-63. PubMed ID: 17639185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
